Items where Funder is Janssen-Cilag Ltd.

Up a level
Export as [feed] Atom [feed] RSS
Group by: Grant number | Institution | No Grouping
Jump to: 4200822156 | A15790 | PCI-32765CLL3003 Ibrutin
Number of items: 3.

4200822156

Collett, L, Howard, DR orcid.org/0000-0003-3333-9783, Munir, T et al. (11 more authors) (2017) Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial. Trials, 18. 387. ISSN 1745-6215

A15790

Collett, L, Howard, DR orcid.org/0000-0003-3333-9783, Munir, T et al. (11 more authors) (2017) Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial. Trials, 18. 387. ISSN 1745-6215

PCI-32765CLL3003 Ibrutin

Collett, L, Howard, DR orcid.org/0000-0003-3333-9783, Munir, T et al. (11 more authors) (2017) Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial. Trials, 18. 387. ISSN 1745-6215

This list was generated on Fri May 3 04:14:20 2024 BST.